Investor Watch | Neuron23 picks up $100M and a new Parkinson's disease candidate
2 years ago
51
Join The Conversation! | https://trialsitenews.com/
Neuron23, a biotech company focused on developing precision medicines for neurological and immunological diseases, has been receiving support from Westlake Village BioPartners and Kleiner Perkins for series A and B of drug development. However, as for the most recent round of funding, they got a huge boost from a reputable investor, the SoftBank Vision Fund.
The SoftBank Vision Fund, a sub-category of SoftBank Group Corp., invested a whopping 100 million dollars into the series C, accounting for nearly half of the 213.5 million in total financing. With this funding, the young biotech company now plans for a clinical trial by the end of the year.
Loading comments...
-
LIVE
Drew Hernandez
11 hours agoTRUMP RALLY UNIONDALE NEW YORK
2,499 watching -
1:15:06
Michael Franzese
4 hours agoTrump assassination attempt & fact checking Harris | Michael Franzese LIVE! Ep. 18
19.8K9 -
1:55:58
Melonie Mac
3 hours agoGo Boom Live Ep 21!
17.7K7 -
1:40:08
Redacted News
5 hours agoSHOCK! Secret Service admits it CAN'T stop more Trump Assassination Attempts | Redacted Live
103K230 -
50:56
Candace Show Podcast
5 hours agoExploding Pagers In Lebanon! Is This Terrorism? | Candace Ep 67
164K624 -
2:10:06
Akademiks
5 hours agoDiddy Bail Appeal Hearing -- This will Determine if Diddy will be Free or Jailed til Trial!
80.4K16 -
1:15:56
Savanah Hernandez
4 hours agoKamala Harris vows to end your 1st and 2nd amendment rights
42K30 -
1:04:17
WarRoom Films
6 days agoGovernment Gangsters - WarRoom Film
78.7K16 -
42:39
RepMattGaetz
6 hours agoEpisode 172 LIVE: The Jeff Clark Story (feat. Jeff Clark) – Firebrand with Matt Gaetz
49K13 -
1:55:09
Matt Kohrs
9 hours agoFed Powell Speech & FOMC Rate Decision (Market Chaos!!!)
51.8K3